< Back to Article

Unraveling potential EGFR kinase inhibitors: Computational screening, molecular dynamics insights, and MMPBSA analysis for targeted cancer therapy development

Fig 5

The change in distance between the ligands and side chain residues of EGFR proteins.

A) 1M17-Ligand complexes, and B) 1XKK-Ligand complexes, respectively.

doi: https://doi.org/10.1371/journal.pone.0321500.g005